CDK1 and head and neck squamous cell carcinoma: Since the phosphorylation level of cell‐cycle checkpoint CDK1/2 was increased, we evaluated the viability of HNSCC cells treated with different rhLTA concentrations and observed significantly higher cell viability (Figure 7H).